#ThinkSabio US Market Morning Brief

Pre-Market Gainers
$GSAT + 67%: GSAT and AAPL updated their service agreements
$TOVX +47 %: Theriva Biologics Selected as Finalist in International Competition for Merck KGaA's EMEA Advance Biotech Grant (Oct 31)
$VSME + 40%

Pre-Market Decliners:
$EPIX - 70%: ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer (Oct 31)
$LXRX - 34%: Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease (Oct 31)

Pre-Market Penny Gainers:
$ICCT + 27%
$ATHA + 23%: Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting (Oct 22)

Headlines
$META Meta's Llama used by Chinese researchers to build AI model for military use - report
$BA Boeing said to dismantle diversity department, DEI head quits
$TSM TO RECEIVE $ASML'S NEXT-GEN CHIP MACHINES THIS YEAR AS CHIP RACE HEATS UP
$AAPL Apple files to offer debt securities